Squarepoint
NEOS

Squarepoint’s Neos Therapeutics, Inc NEOS Stock Holding History

Squarepoint’s Portfolio NEOS Stock Details NEOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,220
Closed -$7K – 3421
2020
Q3 		$7K Sell
13,220
-7,554
-36% -$5.13K ﹤0.01% 2430
2020
Q2 		$14K Buy
+20,774
New +$16.5K ﹤0.01% 2160
2018
Q3 		– Sell
-16,500
Closed -$103K – 2326
2018
Q2 		$103K Buy
16,500
+4,300
+35% +$32.1K ﹤0.01% 1641
2018
Q1 		$101K Sell
12,200
-18,828
-61% -$180K ﹤0.01% 1572
2017
Q4 		$316K Buy
+31,028
New +$298K 0.01% 1465

Other funds holding NEOS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Squarepoint's NEOS Position: Q4 2020 in Review

Squarepoint sold out of Neos Therapeutics, Inc (NEOS) in Q4 2020, closing a stake of 13,220 shares — an estimated $7K sold.

Squarepoint first reported a position in NEOS in Q4 2017 and held it in 5 quarters. The position peaked at $316K in Q4 2017. 37 funds tracked by Wall St. Rank hold NEOS as of Q4 2020.

  • Squarepoint reported no remaining Neos Therapeutics, Inc position as of Q4 2020 after selling out during the quarter.
  • Squarepoint sold 13,220 Neos Therapeutics, Inc shares in Q4 2020, an estimated $7K.
  • Squarepoint first reported a position in Neos Therapeutics, Inc in Q4 2017 and held it in 5 quarters.
  • Squarepoint's Neos Therapeutics, Inc position peaked at $316K in Q4 2017.
  • 37 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q4 2020.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.